思泰瑞醫療 STE 深 滬
等待開盤 08-01 09:30:00 美东时间
228.40
-2.810
-1.22%
華盛通- 最 高230.13
- 今 開228.38
- 成交量 82.88万股
- 最 低 227.67
- 昨 收 231.21
- 總市值 2225.93万
- 52周最高 268.18
- 市盈率 靜 28.82
- 換手率 0.85%
- 52周最低 194.51
- 委 比 -48.15%
- 總股本 9.75万
- 歷史最高 268.18
- 量 比 1.08
- 振 幅 1.06%
- 歷史最低 8.00
- 每 手 1
- 風險率 18.34%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅129.15%！HC Wainwright & Co.升Q32 Bio(QTTB)目标价至36美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Q32 Bio"买入"评级，目标价从13美元升至36美元；Chardan Capital：维持ProMIS Neurosciences"买入"评级，目标价从20美元升至33美元
07-29 11:37
UBS Initiates Coverage On Steris with Buy Rating, Announces Price Target of $275
UBS analyst Patrick Wood initiates coverage on Steris (NYSE:STE) with a Buy rating and announces Price Target of $275.
07-29 02:24
7月17日投资避雷针：美股半导体板块再度大跌 SK海力士、闪迪跌超12%
导读：财联社7月17日投资避雷针，近日A股及海外市场潜在风险事件如下。国内经济信息方面包括：1）国内期货主力合约夜盘跌多涨少，纯碱夜盘跌超2%；2）较历史峰值收...
07-17 08:08
财报速睇 | 思泰瑞医疗 2026财年年度营收59.36亿美元，同比增长8.7%；归母净利润7.82亿美元，同比增长27.3%
华盛资讯5月30日讯，思泰瑞医疗公布2026财年年度业绩，公司年度营收59.36亿美元，同比增长8.7%，归母净利润7.82亿美元，同比增长27.3%。
05-30 04:49
美股大行评级 | 潜在涨幅257.14%！瑞杰金融上调InflaRx目标价至9美元，评级升至"强烈买入"
今日重点评级关注：瑞杰金融：上调InflaRx评级至"强烈买入"，目标价从7美元升至9美元；巴克莱：维持Orchestra BioMed Hldgs"超配"评级，目标价从12美元升至13美元
05-14 14:32
Keybanc Maintains Overweight on Steris, Lowers Price Target to $269
Keybanc analyst Brett Fishbin maintains Steris (NYSE:STE) with a Overweight and lowers the price target from $291 to $269.
05-13 20:54
Transcript: Steris Q4 2026 Earnings Conference Call
Steris (NYSE:STE) released fourth-quarter financial results and hosted an earni...
05-12 22:08
STERIS Board Approves $1B Share Buyback Program
Shares may be repurchased from time to time through open market transactions, including 10b5-1 plans. The repurchase program may be suspended or discontinued at any time.
05-12 04:55
STERIS shares are trading higher after the company reported Q4 financial results and issued FY27 adjusted EPS guidance with its midpoint above estimates. Also, the company issued FY27 sales guidance above estimates.
STERIS shares are trading higher after the company reported Q4 financial result...
05-12 04:47
Steris Sees FY2027 Adj EPS $11.10-$11.30 vs $11.10 Est; Sees Sales $6.352B-$6.411B vs $6.316B Est
Steris (NYSE:STE) is looking for FY2027 Adj EPS of $11.10-$11.30 vs $11.10 analyst estimate. sees sales of $6.352 billion-$6.411 billion vs $6.316 billion analyst estimate.
05-12 04:34
